Literature DB >> 18475328

Quinolones for the treatment of Neisseria gonorrhoeae and Chlamydia trachomatis.

S Faro1.   

Abstract

The most commonly sexually transmitted bacteria are Neisseria gonorrhoeae and Chlamydia trachomatis. The quinolones ofloxacin and ciprofloxacin have been shown to have activity against both of these bacteria in vitro and in vivo. Ofloxacin is particularly well suited for the treatment of N. gonorrhoeae and C. trachomatis cervical infection, which can be considered the earliest manifestation of pelvic inflammatory disease (PID). Not only can ofloxacin be effectively used as a single agent, it is also useful in treating urinary tract infections caused by Enterobacteriaceae. Although it has moderate activity against anaerobes in general, ofloxacin does have activity against the anaerobes commonly isolated from female patients with soft tissue pelvic infections. Thus, ofloxacin has the potential for being utilized to treat early salpingitis.

Entities:  

Year:  1993        PMID: 18475328      PMCID: PMC2364295          DOI: 10.1155/S1064744993000250

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  31 in total

1.  1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Authors:  G Y LESHER; E J FROELICH; M D GRUETT; J H BAILEY; R P BRUNDAGE
Journal:  J Med Pharm Chem       Date:  1962-09

2.  Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains.

Authors:  J M Covino; M Cummings; B Smith; S Benes; K Draft; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  DNA gyrase: an enzyme that introduces superhelical turns into DNA.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; H A Nash
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Serum IgG and IgA antibodies to Chlamydia in ectopic pregnancies.

Authors:  W Chaim; B Sarov; I Sarov; B Piura; A Cohen; V Insler
Journal:  Contraception       Date:  1989-07       Impact factor: 3.375

5.  Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin.

Authors:  J Paavonen; P L Roberts; C E Stevens; P Wølner-Hanssen; R C Brunham; S Hillier; W E Stamm; C C Kuo; T DeRouen; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1989-07       Impact factor: 8.661

6.  Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.

Authors:  B E Batteiger; R B Jones; A White
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

7.  Pharmacokinetics of ofloxacin. An overview.

Authors:  S Flor
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

8.  Single-dose efficacy of ofloxacin in uncomplicated gonorrhea.

Authors:  F B Lutz
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

9.  Should women be tested for gonococcal infection of the cervix during routine gynecologic visits? An economic appraisal.

Authors:  R S Phillips; C Safran; M D Aronson; W C Taylor
Journal:  Am J Med       Date:  1989-03       Impact factor: 4.965

Review 10.  In vitro activity of ofloxacin against Chlamydia trachomatis.

Authors:  J Schachter; J V Moncada
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.